A patient is being admitted to the floor following a motor vehicle accident. because of the stressful nature of the event, the nurse anticipates the patient will continue to have a sympathetic reaction during the post operative period. When monitoring the patient's serum electrolytes, what will the nurse closely monitor?

A) Suspect worsening of the anxiety disorder:
While it is possible that the patient's anxiety disorder is worsening, the more likely explanation for the reduced effectiveness of lorazepam is the development of drug tolerance. Over time, patients may require higher doses of a medication to achieve the same therapeutic effect, especially with medications like lorazepam that are used chronically.

B) Contact the provider to discuss changing to another benzodiazepine:
Changing to another benzodiazepine might be an option, but it is more likely that tolerance to lorazepam is the cause of the reduced effect, not an issue with the specific drug. Tolerance is common with long-term use of benzodiazepines, and switching drugs may not address the underlying issue. The first step would be to assess the current medication regimen and discuss possible adjustments with the provider.

C) Understand that the patient has developed tolerance to this drug:
Tolerance occurs when the body becomes accustomed to the effects of a medication over time, requiring higher doses to achieve the same therapeutic effect. This is a common phenomenon with benzodiazepines like lorazepam, which are often used for long periods to manage anxiety. As the patient has been taking lorazepam for six months, this reduced effectiveness is likely due to the development of tolerance, rather than a worsening of the anxiety disorder.

D) Notify the provider and discuss increasing the dose of lorazepam:
While increasing the dose of lorazepam could temporarily relieve symptoms, it is not the most appropriate first step. The nurse should first consider the possibility of tolerance and discuss this with the provider before increasing the dose. Long-term increases in benzodiazepine dosages can increase the risk of side effects, dependency, and withdrawal symptoms.

A) Reversal of bronchoconstriction: Narcotic antagonists are not used to reverse bronchoconstriction. Bronchoconstriction is typically managed with bronchodilators (such as beta-agonists) or corticosteroids. Narcotic antagonists, such as naloxone, specifically counteract the effects of opioids, not respiratory conditions like bronchoconstriction.

B) Reversal of tachycardia: Narcotic antagonists do not have an effect on reversing tachycardia. Tachycardia may result from various conditions, including stimulant use, dehydration, or heart conditions. Treatment for tachycardia typically involves addressing the underlying cause, such as using beta-blockers for cardiac issues, but not narcotic antagonists.

C) Treatment of alcohol dependence: While certain medications, like disulfiram or acamprosate, are used to treat alcohol dependence, narcotic antagonists are not typically indicated for alcohol dependence. Narcotic antagonists, such as naloxone, are primarily used for opioid overdose or dependence, not for alcohol use disorders.

D) Treatment of narcotic dependence: Narcotic antagonists, such as naloxone, are prescribed in the treatment of narcotic (opioid) dependence. These medications work by blocking the effects of opioids at the receptor sites, thereby preventing the "high" associated with opioid use. They are particularly useful in treating opioid overdoses and can also be used in the management of opioid addiction as part of a comprehensive treatment plan.